Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
FDA Warning Letters
February 2, 2004
1 Min Read
FDA Warning Letters
ROCKVILLE, Md.Recent warningletters from the Food and Drug Administration (FDA) were sent to two companiesusing dubious claims. In a Nov. 6 letter, American Nutraceuticals Co. of Atlantawas warned about using drug-like claims such as clinically proven to reducecholesterol levels for its product Cholester LOW 2, among others.NutraLife Laboratories of Anaheim, Calif., was sent a Dec. 16 letter aboutproducts such as NiControl, which also bore drug-like claims.
You May Also Like